Work

1505MO Improving cancer care through broader access to quality biomarker testing: An IQN Path, ECPC and EFPIA initiative

Year: 2021

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2021.08.834

Authors: N. Normanno, K. Apostolidis, M. Akkermans, R. Al Dieri, C. Bedard Pfeiffer, I. Cattaneo, Z.C. Deans, J. Emch, J.A. Fairley, P. Fivey, S. Hall, J. Maas, A. Martinez, H. Moch, S. Nielsen, T. Pilz, E. Rouleau, P.J. Simon, M. van Meerveld, N. Wolstenholme

Institutions: Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", MSD (Switzerland), F. Hoffmann-La Roche AG, Novartis (Italy), GlaxoSmithKline (United States), AstraZeneca (United Kingdom), Novartis (United Kingdom)

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: bronze

OpenAlex ID: W3203463677

FWCI: 0.086

Cites:

Cited by: 2

Related to: 10